ZBH

ZBH

USD

Zimmer Biomet Holdings Inc. Common Stock

$103.180+3.170 (3.170%)

Precio en Tiempo Real

Healthcare
Dispositivos médicos
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$100.010

Máximo

$103.690

Mínimo

$99.455

Volumen

9.20M

Fundamentos de la Empresa

Capitalización de Mercado

20.4B

Industria

Dispositivos médicos

País

United States

Estadísticas de Negociación

Volumen Promedio

1.41M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $89.22Actual $103.180Máximo $114.72

Noticias Relacionadas

PR Newswire

Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has ...

Ver más
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
Analyst Upgrades

Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Maintains $101 Price Target

Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings with a Hold and maintains $101 price target.

Ver más
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Maintains $101 Price Target
PR Newswire

Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting bold innovations across ...

Ver más
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
Analyst Upgrades

BTIG Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $122

BTIG analyst Ryan Zimmerman maintains Zimmer Biomet Holdings with a Buy and raises the price target from $118 to $122.

Ver más
BTIG Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $122
PR Newswire

Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, a wholly owned subsidiary, today announced the...

Ver más
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases
Analyst Upgrades

Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Lowers Price Target to $104

Evercore ISI Group analyst Vijay Kumar maintains Zimmer Biomet Holdings with a In-Line and lowers the price target from $106 to $104.

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.